3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Neuroendocrine Tumors
4
Serotonin Syndrome
2
Carcinoid Tumor
2
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors in Lung
1
Intestinal Obstruction
1
Growth Hormone-Secreting Pituitary Adenoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Flushing
1
Endocrine Tumors
1
Diarrhea
1
Carcinoma
1
Carcinoid Heart Disease
1
Adenoma, Islet Cell
1
Acromegaly
1
Interventions
pasireotide
2
Cabergoline
2
lanreotide
1
Solutions
1
Radiosurgery
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pituitary Neoplasms
×
lanreotide
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled